Boehringer Ingelheim is a pharmaceutical company, family-owned since it was established in 1885. Some 50,000 employees create value through innovation daily for the three business areas: human pharmaceuticals, animal health, and biopharmaceuticals. They recently launched a new department to pursue impact investing. Based in Ingelheim am Rhein, Germany.